Dipyridamole

An intertnal standard for the quantification of 2,3-dinor TXB2 by GC- or LC-MS.

11-dehydro-2,3-dinor TXB2 has been identified as a TXB2 metabolite in human urine by GC/MS. The relative abundance is only about one-tenth that of 11-dehydro TXB2, making it unlikely that 11-dehydro-2,3-dinor TXB2 will be used widely as an index of

An inhibitor of PDE1 that has diverse cerebral and neurological effects in vivo also directly inhibits IKK&beta (IC₅₀ = 17 &microM in a cell-free system) and blocks TNF-&alpha- and LPS-mediated activation of NF-&kappaB in cells and

An endogenous CB neurotransmitter that binds to both CB1 and CB2 receptors.

11-dehydro-2,3-dinor TXB2 has been identified as a TXB2 metabolite in human urine by GC/MS. The relative abundance is only about one-tenth that of 11-dehydro TXB2, making it unlikely that 11-dehydro-2,3-dinor TXB2 will be used widely as an index of

11-dehydro TXB2-d4 contains 4 deuterium atoms at the 3, 3&#39, 4, and 4&#39 positions. It is intended for use as an internal standard for the quantification of 11-dehydro TXB2 by GC- or LC-mass spectrometry.

A PDE5A inhibitor (IC₅₀ = 574 nM) that prevents platelet aggregation by increasing cGMP levels and blocking the reuptake of adenosine via red blood cells scavenges the free radicals that inactivate COX, leading to the inhibition of

An endogenous CB neurotransmitter that binds to both CB1 and CB2 receptors.

11-dehydro-2,3-dinor TXB2 has been identified as a TXB2 metabolite in human urine by GC/MS. The relative abundance is only about one-tenth that of 11-dehydro TXB2, making it unlikely that 11-dehydro-2,3-dinor TXB2 will be used widely as an index of

An inhibitor of PDE1 that has diverse cerebral and neurological effects in vivo also directly inhibits IKK&beta (IC₅₀ = 17 &microM in a cell-free system) and blocks TNF-&alpha- and LPS-mediated activation of NF-&kappaB in cells and

A PDE5A inhibitor (IC₅₀ = 574 nM) that prevents platelet aggregation by increasing cGMP levels and blocking the reuptake of adenosine via red blood cells scavenges the free radicals that inactivate COX, leading to the inhibition of

An inhibitor of PDE1 that has diverse cerebral and neurological effects in vivo also directly inhibits IKK&beta (IC₅₀ = 17 &microM in a cell-free system) and blocks TNF-&alpha- and LPS-mediated activation of NF-&kappaB in cells and